Patents by Inventor Frederic Champavere

Frederic Champavere has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Derivatives of the aminated hydroxyquinoline class for treating cancers
    Patent number: 8614230
    Abstract: The invention relates to compounds of the aminated hydroxyquinoline type capable of preventing the migration of metastases or tumoral cells. Such compounds are useful for treating cancers.
    Type: Grant
    Filed: November 30, 2012
    Date of Patent: December 24, 2013
    Assignee: Biopharmed
    Inventors: Jean-Louis Kraus, Olivier Blin, Frederic Champavere
  • Derivatives of the aminated hydroxyquinoline class for treating cancers
    Patent number: 8324243
    Abstract: The invention relates to compounds of the aminated hydroxyquinoline type capable of preventing the migration of metastases or tumoral cells. Such compounds are useful for treating cancers.
    Type: Grant
    Filed: March 25, 2008
    Date of Patent: December 4, 2012
    Assignee: Biopharmed
    Inventors: Jean-Louis Kraus, Olivier Blin, Frederic Champavere
  • PPAR AGONIST COMPOSITIONS AND METHODS OF USE
    Publication number: 20110251238
    Abstract: Method for treating or preventing a PPAR-responsive condition in a subject, comprising administering to the subject a PPAR agonist that comprises a 8-hydroxyquinoline-methylene-N- group in an amount effective to activate a PPAR polypeptide.
    Type: Application
    Filed: December 23, 2009
    Publication date: October 13, 2011
    Applicant: BIOPHARMED
    Inventors: Jean-Louis Kraus, Olivier Blin, Frédéric Champavere
  • Derivatives of the Aminated Hydroxyquinoline Class For Treating Cancers
    Publication number: 20100120856
    Abstract: The invention relates to compounds of the animated hydroxyquinoline type capable of preventing the migration of metastases or tumoral cells. Such compounds are useful for treating cancers.
    Type: Application
    Filed: March 25, 2008
    Publication date: May 13, 2010
    Applicant: BIOPHARMED
    Inventors: Jean-Louis Kraus, Olivier Blin, Frederic Champavere